ATOS
ATOSSA THERPTCS (ATOS)
NASDAQ
$4.71-$0.14 (-2.99%)
Price as of Jun 03, 2026 6:45 PM EDT
  • $45.0M
    Market Cap
  • -62.06%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-21.2M
+50.07%
-14.1M
-18.56%
-17.3M
+14.92%
-15.1M
+63.77%
Depreciation and Amortization Expense
16,000
-5.88%
17,000
-26.09%
23,000
+187.50%
8,000
-65.22%
Total Operating Expenses
37.1M
+34.47%
27.6M
-11.97%
31.4M
+13.31%
27.7M
+34.94%
Operating Profit
-37.1M
+34.47%
-27.6M
-11.97%
-31.4M
+13.31%
-27.7M
+34.94%
Interest Income
2.4M
-41.31%
4.0M
-6.75%
4.3M
+395.21%
877,000
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
2.4M
-41.31%
4.0M
-6.75%
4.3M
+395.21%
877,000
N/A
Total Nonoperating Income and Expense
-6,000
-97.31%
-223,000
+218.57%
-70,000
-52.05%
-146,000
+71.76%
Income before Taxes
-34.8M
+36.33%
-25.5M
-15.25%
-30.1M
+11.62%
-27.0M
+30.84%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-34.8M
+36.33%
-25.5M
-15.25%
-30.1M
+11.62%
-27.0M
+30.84%
Net Income from Continuing Operations Applicable to Common
-34.8M
+36.33%
-25.5M
-15.25%
-30.1M
+11.62%
-27.0M
+30.84%
Basic EPS and Net Income
-4.04
+1,920.00%
-0.20
-16.67%
-0.24
+14.29%
-0.21
+16.67%
Diluted EPS and Net Income
-4.04
+1,920.00%
-0.20
-16.67%
-0.24
+14.29%
-0.21
+16.67%
Basic Weighted Average Shares
8.6M
-93.16%
125.9M
-0.18%
126.1M
-0.43%
126.6M
+108,171.91%
Diluted Weighted Average Shares
8.6M
-93.16%
125.9M
-0.18%
126.1M
-0.43%
126.6M
+108,171.91%
Balance Sheet
Cash and Cash Equivalents
41.3M
-41.90%
71.1M
-19.64%
88.5M
-20.23%
110.9M
-18.69%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
41.3M
-41.90%
71.1M
-19.64%
88.5M
-20.23%
110.9M
-18.69%
Total Current Assets
45.6M
-38.73%
74.5M
-19.26%
92.2M
-21.98%
118.2M
-16.31%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
2.0M
+0.15%
2.0M
-14.46%
2.3M
+265.83%
635,000
+31,650.00%
Total Assets
47.6M
-37.72%
76.4M
-20.58%
96.3M
-22.08%
123.5M
-12.55%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
8.3M
+66.20%
5.0M
-5.14%
5.2M
-5.96%
5.6M
+78.12%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Liabilities
8.3M
+66.20%
5.0M
-5.14%
5.2M
-5.96%
5.6M
+78.12%
Retained Earnings
-246.6M
+16.42%
-211.8M
+13.69%
-186.3M
+19.27%
-156.2M
+20.86%
Total Stockholders Equity
39.4M
-44.94%
71.5M
-21.47%
91.0M
-22.84%
118.0M
-14.60%
Total Shares Outstanding
15
-100.00%
129.2M
+3.09%
125.3M
-1.04%
126.6M
0.00%
Cash Flow
Cash from Operating Activities
-29.8M
+41.52%
-21.0M
+0.43%
-20.9M
+0.87%
-20.8M
+26.03%
Capital Expenditures
23,000
+21.05%
19,000
+35.71%
14,000
-48.15%
27,000
+200.00%
Cash from Investing Activities
-23,000
+21.05%
-19,000
+35.71%
-14,000
-99.70%
-4.7M
+52,422.22%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
0
-100.00%
3.7M
+349.02%
-1.5M
N/A
0
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-56.06%
+89.79%
-29.54%
+7.86%
-27.39%
+34.48%
-20.36%
-9.03%
Return on Equity
-62.74%
+99.88%
-31.39%
+8.99%
-28.80%
+36.79%
-21.05%
-15.55%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.53
-63.14%
14.99
-14.89%
17.61
-17.03%
21.23
-53.02%
Cash Ratio
5.00
-65.04%
14.31
-15.29%
16.89
-15.17%
19.92
-54.35%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow